StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.98−0.03 (-3.28%)

Close on Nov 18, 2026Market cap $18.82MP/E –Yield –

Cocrystal Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cocrystal Pharma's price to sales ratio was 41.3× on Apr 30, 2021, against 5.0× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 202141.3×−7.7
2020Dec 31, 202048.9×–

More Cocrystal Pharma figures

See a number that looks wrong?